CompoAtlas

Ashwagandha Max (120 gélules)

Food supplement declared in France, decision dated 12 February 2026

Ashwagandha Max (120 gélules) (Superset Nutrition) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 250 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Superset Nutrition
Food business operator placing the product on the market
FITCORP
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2 gélules par jour
Directions for use
Prendre 2 gélules par jour avec un grand verre d’eau. Prendre une dose par jour.
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women, Heart problems, Liver problems, Taking antidepressants, Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Sport, Mood, Nervous system

Declaration 356632, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineExtrait sec hydroalcoolique250 mg

Additives

E464, E530

Other ingredients

maltodextrine, farine de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. Réservé aux adultes. Déconseillé aux femmes enceintes et allaitantes ainsi que chez les personnes sous traitement antidépresseur. Déconseillé pour les personnes atteintes de troubles endocriniens (particulièrement les dysthyroïdies et l’hyperandrogénie) et pour les personnes atteintes de troubles hépatiques ou cardiaques. Tenir hors de portée des enfants.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Superset Nutrition

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ashwagandha Max (120 gélules) (Superset Nutrition): composition and regulation”, https://compoatlas.com/en/supplements/products/356632-ashwagandha-max-120-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line